DOI: http://dx.doi.org/10.18203/2349-3933.ijam20183832

Effects of smoking cessation on pulmonary function and quality of life

Ramesh P. M., Saravanan M., Divya .

Abstract


Background: Cigarette smoking is a major public health problem and is the most important cause of chronic obstructive pulmonary disease (COPD). This study shows the importance of smoking cessation for improvement in respiratory function and quality of life and brings out the potential usage of pharmacological and behavioural therapy for the same.

Methods: This prospective study was conducted on 50 male smokers at Kilpauk Medical College, Chennai. During the treatment only 43 patients were continued till the end of follow up. During the period, varenicline treatment was given for three months as per schedule, regular periodic counselling was given to these patients and followed up for a period of 1 year. Forced expiratory volume at one second (FEV1), COPD assessment test (CAT) scoring, 6 min walk test (6MWD), BODE index, was taken before starting therapy and on 3rd month and at the end of one year of follow-up. All the values obtained were analysed statistically.

Results: The mean age of the 43 patients was 44.7±7.34, mean BMI was 22.27±4.24. The mean difference between pre and post treatment scores of CAT, 6MWD and BODE index were found to be statistically significant (p<0.0001).

Conclusions: Combined behavioural counseling and pharmacotherapy with varenicline significantly improved the odds of achieving tobacco abstinence in the participants by the end of one year of treatment.


Keywords


BODE index, COPD assessment test, Quality of life, 6MWD

Full Text:

PDF

References


Tomioka H, Sekiya R, Nishio C, Ishimoto G. Impact of smoking cessation therapy on health-related quality of life. BMJ Open Resp Res. 2014;1:e000047.

Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson A, Jönsson E, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003;97:115-22.

Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, et al. Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc. 2008;5(8):811-5.

Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994;272(19):1497-505.

Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, et al. Smoking cessation and lung function in mild-to moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000;161(2 Pt 1):381-90.

Godtfredsen NS, Prescott E. Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities. Clin Respir J. 2011;5:187-94.

Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-54.

Seemungal TA, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD -a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009;4(1):203-23.

Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med. 2011;11:42.

Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29-35.

Lin YX, Xu WN, Liang LR, Pang BS, Nie XH, Zhang J, et al. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease. Chinese Med J. 2009;122(24):2939-44.

Amorós MM, Mas-Tous C, Renom-Sotorra F, Rubi-Ponseti M, Centeno-Flores MJ, et al. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chronic Respi Dis. 2009;6(2):75-80.

Medinas-Amorós M, Alorda C, Renom F, Rubí M, Centeno J, Ferrer V, et al. Quality of life in patients with chronic obstructive pulmonary disease: the predictive validity of the BODE index. Chronic Respiratory Dis. 2008;5(1):7-11.

Balke B. A simple field test for the assessment of physical fitness. Civil Aerospace Medical Institute. 1963;(53):1-8.

O'Keeffe ST, Lye M, Donnellan C, Carmichael DN. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart. 1998;80(4):377-82.

Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. American J Resp Critical Care Med. 1998;158(4):1185-9.

Mudge S, Stott NS. Timed walking tests correlate with daily step activity in persons with stroke. Arch Physical Med Rehabilitation. 2009;90(2):296-301.

Drugbank. Varenicline. Available at: https://www.drugbank.ca/drugs/DB01273. Accessed on 10th February 2018.

Tran K, Asakawa K, Cimon K, Moulton K, Kaunelis D, Pipe A, et al. Pharmacologic-based Strategies for Smoking Cessation: Clinical and Cost-Effectiveness Analyses Ottawa: Canadian Agency for Drugs and Technologies in Health; 2010. (Technology Report; no. 130). Available at: http://www.cadth.ca/index.php/en/hta/reports-publications/search?&type=16. Accessed on 11 Feb 2011.

Tashkin DP, Rennard S, Taylor Hays J, Lawrence D, Marton d JP, et al. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Respiratory Med. 2011;105(11):1682-90.

Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Sonia Buist A, e Lung Health Study Research Group DP. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the lung health study. Am J Resp Critical Care Med. 2000 Feb 1;161(2):381-90.

Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002;166(5):675-9.

Polosa R, Morjaria JB, Caponnetto P, Prosperini U, Russo C, Pennisi A, et al. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir Res. 2016;17(1):166.

Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. New England J Med. 2004;350(10):1005-12.